loading page

Phenotype and severity of asthma determines bronchial epithelial immune responses to a TLR3 agonist
  • +8
  • Celeste Porsbjerg,
  • Juan Nieto-Fontarigo,
  • Samuel Cerps,
  • Sangeetha Ramu,
  • Mandy Menzel,
  • Morten Hvidtfeldt,
  • Silberbrandt A,
  • Froessing L,
  • Ditte Klein,
  • Asger Sverrild,
  • Lena Uller
Celeste Porsbjerg
Bispebjerg Hospital

Corresponding Author:[email protected]

Author Profile
Juan Nieto-Fontarigo
Skanes universitetssjukhus Lund
Author Profile
Samuel Cerps
Skanes universitetssjukhus Lund
Author Profile
Sangeetha Ramu
Skanes universitetssjukhus Lund
Author Profile
Mandy Menzel
Bispebjerg Hospital
Author Profile
Morten Hvidtfeldt
Bispebjerg Hospital
Author Profile
Silberbrandt A
Bispebjerg Hospital
Author Profile
Froessing L
Bispebjerg Hospital
Author Profile
Ditte Klein
Bispebjerg Hospital
Author Profile
Asger Sverrild
Bispebjerg Hospital
Author Profile
Lena Uller
Skanes universitetssjukhus Lund
Author Profile

Abstract

Background Asthma is characterized by an aggravated immune response to respiratory viral infections: This phenomenon is a clinically well-recognized driver of acute exacerbations, but how different phenotypes of asthma respond immunologically to virus is unclear. Objectives To describe the association between different phenotypes and severity of asthma and bronchial epithelial immune responses to viral stimulation. Methods In the Immunoreact study, healthy subjects (n=10) and 50 patients with asthma were included; 30 (60%) were atopic, and 34 (68%) were eosinophilic; 15 (25%) had severe asthma. All participants underwent bronchoscopy with collection of bronchial brushings. Bronchial epithelial cells (BECs) were expanded and stimulated with the viral replication mimic poly (I:C) (TLR3 agonist) in vitro. The expression of TLR3-induced pro-inflammatory and anti-viral responses of BECs were analyzed using RT-qPCR and multiplex ELISA and compared across asthma phenotypes and severity of disease. Results Patients with atopic asthma had increased production of IL-4, IFN-β, IL-6, TNF-α, and IL-1β after poly (I:C) stimulation compared to non-atopic patients, whereas patients with eosinophilic asthma and non-eosinophilic asthma did not differ in the response to poly (I:C). Patients with severe asthma displayed a decreased antiviral IFN-β, and increased expression of IL-8, most pronounced in atopic and eosinophilic asthmatics. Interestingly, release of IL-33 and TSLP in response to poly (I:C) was increased in severe eosinophilic asthma, but not in severe atopic asthma. Conclusions The bronchial epithelial immune response to a viral mimic stimulation differs between asthma phenotypes and severities, which may be important to consider when targeting novel asthma treatments.